Patent ID: 11939354
Assignee: KING FAISAL UNIVERSITY
Field: Biotechnology (Chemistry)
Classification: CPC C  A | IPC A  C  G

Claim 0:
1. A method for conducting a human coronavirus 229E inhibition assay comprising:
(a) providing a HCoV-229E peptide inhibitor;
(b) providing a test inhibitor;
(c) assaying the HCoV-229E peptide inhibitor to obtain results for the HCoV-229E peptide inhibitor;
(d) assaying the test inhibitor to obtain results for the test inhibitor; and
(e) comparing the results for the HCoV-229 peptide inhibitor to the results for the test inhibitor to determine whether the test inhibitor inhibits HCoV-229 fusion;, wherein the HCoV-229E peptide inhibitor is selected from the group consisting of a peptide consisting of the amino acid sequence of SEQ ID NO: 2, a peptide consisting of the amino acid sequence of SEQ ID NO: 3, and a peptide consisting of the amino acid sequence of SEQ ID NO: 2 and the amino acid sequence of SEQ ID NO: 3, and a combination thereof.